InsidersTradesSigma
Gufic Biosciences Limited: directors' dealings · India · SEBI (PIT + SAST)
SEBI:gufic-biosciences-limitedIN·SEBI (PIT + SAST)Mcap 33.7Bn€
Explore the full insider trade history of Gufic Biosciences Limited, a listed issuer based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €33.7bn. The latest transaction was filed on 3 June 2022 — Sale. Among the most active insiders: JAYESH CHOKSI. All data is free.
7
Insider Decl.
0
Thresholds
€215,153
3 ops.
Buy Volume
€1m
4 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
277.10 €
Income statement
Revenue7.46 Bn€
Gross profit3.63 Bn€49% margin
Net income696.5 M€9.3% margin
Balance sheet & cash
Market cap33.74 Bn€
Total debt3.36 Bn€
Free Cash Flow470.4 M€
Last declaration on 3 June 2022
Declarations7 total
Executives●Sale0SEBI
€47,64018,000 shares@ €2.6466
Equity Shares
SEBI:493695d46546f678999d809a50b941f94ffbb779·
Executives●Sale0SEBI
€1m450,000 shares@ €2.6133
Equity Shares
SEBI:51ad21351354d733ab586d3740b62710c4644ab7·
Executives●Sale2SEBI
0Equity Shares
SEBI:c6c85b7863ec453db354b785b9352eed00d4ad6b·
Executives●Sale2SEBI
0Equity Shares
SEBI:4e582a9b8c45cd482639310bb2e118b3ea2ba64d·
Executives●Purchase10SEBI
€80,4647,148,570 shares@ €0.01130.0002% mcap100.0% of flow
Equity Shares
SEBI:d58e6e029c9f547b5f7200d1b4400cf24002bdf2·
Ideal exit: 4 Mar 2022 (T+270)
Executives●Purchase10SEBI
€80,4647,148,570 shares@ €0.01130.0002% mcap100.0% of flow
Equity Shares
SEBI:ba718e123ca1ed7b745f51e878396c06e735a158·
Ideal exit: 4 Mar 2022 (T+270)
Executives●Purchase10SEBI
€54,2244,817,366 shares@ €0.01130.0002% mcap100.0% of flow
Equity Shares
SEBI:e24b652c77ee490507ab93106f57c1f4de656bda·
Ideal exit: 4 Mar 2022 (T+270)
7 of 7 declarations